Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical doxepin versus placebo for burn-related pruritus
NL-OMON45341Phase 4Active, not recruiting
- Sponsor
- Association of Dutch Burn Centres
- Start
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of doxepin in pruritus (2 arms), sponsored by Association of Dutch Burn Centres. Primary endpoint: Change in pruritus intensity. Started Jun 2017; status: active, not recruiting.
02
Drugs
doxepin
03
Conditions
pruritus
Beyond the preview
Go deeper on NL-OMON45341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45341.